Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Review Article (Web of Science)

International Collaboration

cited authors

  • Hakoum, Maram B.; Kahale, Lara A.; Tsolakian, Ibrahim G.; Matar, Charbel F.; Yosuico, Victor Ed; Terrenato, Irene; Sperati, Francesca; Barba, Maddalena; Schunemann, Holger; Akl, Elie A.

publication date

  • January 1, 2021




  • Anticoagulants [*therapeutic use]
  • Dalteparin [therapeutic use]
  • Fibrinolytic Agents [therapeutic use]
  • Fondaparinux
  • Hemorrhage [chemically induced]
  • Heparin [therapeutic use]
  • Heparin, Low-Molecular-Weight [therapeutic use]
  • Humans
  • Neoplasms [*complications]
  • Polysaccharides [therapeutic use]
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Secondary Prevention
  • Tinzaparin
  • Venous Thromboembolism [*drug therapy] [mortality]


  • 12